Hemolytic-Uremic Syndrome

This is a serious condition that affects the kidneys. It involves red blood cell destruction, low platelets, and kidney failure. It often follows an infection, especially with certain types of E. coli bacteria.

Condition

What people with Hemolytic-Uremic Syndrome report

Every report comes from a Lived member, sent anonymously.

Have you had Kidney Dialysis for Hemolytic-Uremic Syndrome?

NameHow it went

About Hemolytic-Uremic Syndrome

What It Is

Hemolytic-uremic syndrome (HUS) is a serious illness in which damage to the lining of the body's smallest blood vessels sets off three problems at once. Red blood cells are broken apart as they squeeze through injured vessels (hemolytic anemia). Platelets, the cells that help blood clot, are used up in tiny clots. The kidneys, whose filters are packed with these small vessels, suddenly stop working well. The result can be tiredness and paleness from anemia, easy bruising, and much less urine than usual. There are two main forms, and the difference matters for treatment. The common form, sometimes called typical HUS, follows a gut infection with Shiga toxin-producing E. coli (STEC), most often in young children, and usually happens once. Atypical HUS (aHUS) is a much rarer disease driven by part of the immune system called complement, which attacks the body's own blood vessels when its normal controls fail. It can occur at any age and can come back. HUS is one of the main causes of sudden kidney failure in children.

Causes & Risk Factors

Typical HUS starts with an infection by E. coli strains that make Shiga toxin, most often the O157:H7 strain. The bacteria stay in the gut but release a toxin that enters the bloodstream and injures blood vessels, especially in the kidneys. People usually catch these bacteria from undercooked ground beef, unpasteurized milk, juice or cider, contaminated raw produce, or water in pools and lakes, and the infection can spread from person to person. Children under 5 are most likely to develop HUS after such an infection. Cooking ground beef to 160°F, avoiding unpasteurized drinks, careful handwashing, and keeping children with diarrhea out of pools all lower the risk. Atypical HUS has different roots. About 60 to 70 percent of people with it carry a gene variant that weakens the controls on complement, or have antibodies that block one of those controls (factor H), and a family history of the disease raises suspicion of an inherited form. HUS can also be triggered by some medicines, including certain chemotherapy and transplant drugs, by pregnancy and the weeks after giving birth, and by other infections or illnesses.

How It's Diagnosed

Diagnosis rests on blood and urine tests that show all three parts of the syndrome. A complete blood count shows low hemoglobin (anemia) and a low platelet count. A blood smear, in which the cells are examined under a microscope, shows red cells broken into fragments, a sign they were damaged inside small vessels. Rising creatinine and urea, waste products the kidneys normally clear, show how much kidney function has dropped, and urine tests often find blood and protein. When HUS follows diarrhea, a stool test looks for Shiga toxin or the E. coli that makes it. If that search comes back negative, or the person has no diarrhea, doctors look harder at other causes. A test of an enzyme called ADAMTS13 helps separate HUS from thrombotic thrombocytopenic purpura (TTP), a look-alike condition that is treated differently: severely low ADAMTS13 activity points to TTP rather than HUS. Atypical HUS is diagnosed once typical HUS and TTP have been ruled out, and complement and genetic tests help confirm it and guide long-term decisions, though a normal genetic result does not rule it out. A kidney biopsy is needed only in some cases.

Treatment Options

There is no medicine that stops typical HUS, so treatment supports the body while the blood vessels heal. This happens in the hospital and can include careful fluid and salt management, red blood cell transfusions for severe anemia, medicines to control high blood pressure, and nutrition through a vein if needed. When the kidneys can't keep up, dialysis filters the blood temporarily, and most children who need it need it only for a short time. Doctors generally avoid antibiotics when an STEC infection is suspected, because some have been linked to a higher chance of developing HUS. Atypical HUS is treated by blocking complement. Eculizumab (Soliris) and ravulizumab (Ultomiris) are antibody medicines given by IV infusion that stop complement from damaging blood vessels, and they can halt the disease and allow kidney function to recover. They are not used for typical HUS caused by E. coli. Because they weaken a defense against meningococcal bacteria, people are vaccinated beforehand, or given antibiotics until the vaccines take effect when treatment can't wait. Once treatment is established, eculizumab is usually given every two weeks and ravulizumab less often, and how long to continue is decided case by case, since some people relapse after stopping. Plasma exchange, which replaces the liquid part of the blood, is an option when antibodies to factor H are the cause or complement blockers aren't available. If kidney failure becomes permanent, dialysis or a kidney transplant is needed; in atypical HUS the disease can return in a new kidney, so planning a transplant includes genetic testing and often complement blocking.

What to Expect

Typical HUS usually begins with a few days of stomach cramps, vomiting and diarrhea that often turns bloody. Around a week later, as the diarrhea may be easing, the child or adult becomes pale, tired or irritable and passes less urine. Treatment then takes place in the hospital. The illness can affect other organs too: seizures, confusion or stroke-like symptoms occur in some people and signal a more severe course that often needs intensive care. Most children recover fully, and adults with HUS tend to have a harder course than children. Recovery of blood counts usually comes first, and kidney function improves over the following weeks. Even after a good recovery, regular checks of blood pressure, kidney function and protein in the urine are recommended for years, because in older pooled studies about a quarter of children showed some lasting kidney effect, such as high blood pressure or protein leaking into the urine. Children who had nervous system involvement may benefit from follow-up of development, learning and coordination. Atypical HUS is more often a long-term condition. Many people stay on regular infusions and blood tests, and those who stop treatment are watched closely for relapse. Life between infusions can be fairly normal, but planning around treatment, vaccinations and the cost and access issues of these medicines is part of living with the disease.

When to Seek Help

Bloody diarrhea should be checked by a clinician the same day, especially in a child under 5, so that the infection can be tested for and the person watched for HUS. Don't give anti-diarrhea medicine for bloody diarrhea without checking with a clinician first. During or in the week or two after a diarrheal illness, or while recovering from HUS, get emergency care right away for passing much less urine or none at all, unusual paleness or extreme tiredness, unexplained bruising, bleeding or tiny red spots on the skin, new swelling, drowsiness or confusion, or a seizure. Anyone taking eculizumab or ravulizumab who develops a fever or other signs of infection should seek emergency care immediately because of the risk of meningococcal infection. After recovery, contact the care team if blood pressure readings rise, urine becomes foamy or bloody, or swelling appears, as these can be early signs of kidney strain.

Questions to Ask Your Doctor

  1. 1.Is this typical HUS from an infection or could it be atypical HUS, and what tests will tell us?
  2. 2.How much kidney function has been lost, and what are the chances it will come back?
  3. 3.What follow-up of blood pressure, kidney function and urine protein will we need, and for how long?
  4. 4.If this is atypical HUS, how long should treatment continue, and what would make stopping safe?
  5. 5.Do family members need testing, and is there anything that could set off a relapse that we should watch for?

Last reviewed • Oct 2026

Educational content, not medical advice.